Best Healthcare Software in Brazil - Page 102

The complexity of organizational business operations is increasing, while the lifespan of applications is diminishing. To tackle this business challenge, it is essential to gather relevant data and eliminate the solution once the problem has been addressed. In today's fast-paced environment, Low Code No Code (LCNC) Application Development Platforms facilitate this process. The AmpleLogic LCNC Development Platform features an intuitive drag-and-drop form designer that streamlines workflow by connecting both internal stakeholders and external processes. Utilizing a LCNC platform like AmpleLogic allows you to better address your organization's unique demands and bridge gaps in your business operations, ultimately enhancing overall efficiency and adaptability. By leveraging such tools, organizations can remain agile and responsive in an ever-evolving market landscape.

Kalypso offers a budget-friendly solution for life sciences organizations looking to implement a Regulatory Information Management (RIM) system, known as Accel for RIM. This platform facilitates an integrated approach to effectively oversee and monitor product registrations while enhancing the accuracy of submissions and managing global Unique Device Identification (UDI) information, thereby streamlining product distribution. It also merges compliance and quality data from multiple enterprise systems into a comprehensive source of truth for product registrations and tracking, which expedites regulatory submissions. Utilizing modern APIs, it aggregates product data along with necessary regulatory documentation and submission packages. The system is pre-configured for swift deployment and is built on a validated software framework, grounded in the best practices and successful implementations within the industry. By adopting this solution, companies can expect not only efficiency but also a significant reduction in time spent on regulatory tasks.

PhlexRIM is set to significantly enhance compliance by providing real-time access to global registration data in a highly efficient manner. The latest version, PhlexRIM 2.0, features a collection of pre-configured automation assistants, known as “bots,” along with built-in regulatory scenarios that adhere to industry best practices. With an easy-to-use drag-and-drop design interface, regulatory teams can streamline their business operations without needing programming skills or assistance from IT departments. Furthermore, it allows for effective management of the pharmaceutical product registration lifecycle. Users can access detailed status updates and take advantage of the alert management system integrated into all workflows. Reporting capabilities are also robust, enabling the use of standard reports or the creation of custom reports tailored to specific needs. Additionally, the platform facilitates the creation and assignment of regulatory tasks within various levels of the organization, including management, departments, headquarters, and affiliates, ensuring cohesive collaboration across teams.

Envision having all your regulatory details related to products, registrations, submissions, correspondence, and commitments consolidated in a single, easily accessible location. With Ennov RIM, companies in the life sciences sector can enhance their regulatory workflows, elevate data integrity, swiftly address crucial business inquiries, and efficiently fulfill requests from health authorities. Specifically designed for the oversight and monitoring of therapeutic product information and registration data, Ennov RIM is rooted in Ennov Process. Regardless of whether you are preparing for the introduction of a new product or managing adjustments to current registrations, Ennov RIM equips regulatory teams with essential information and tools to proficiently oversee product portfolios on a global scale. This comprehensive approach not only fosters compliance but also promotes strategic decision-making across the organization.

Enhance the speed at which products reach the market by organizing, implementing, and monitoring all regulatory processes within a cohesive RIM application that offers easy access to regulatory documentation and comprehensive support for major eCTD submission standards. The integrated automation simplifies workflows, minimizing administrative tasks and increasing trust in the quality of product registration data. By utilizing this unified approach, organizations can ensure a more efficient regulatory process while maintaining high standards of compliance and accuracy.

Ensure the accuracy of health records, minimize liability, and enhance resident satisfaction by utilizing a comprehensive electronic health record system tailored specifically for senior living providers. Integrate the EHR seamlessly with all aspects of your senior living operations to lower costs, boost occupancy rates, and improve care quality—covering areas such as property management, accounting, marketing, electronic leasing, customer relationship management, online resident services, and mobile applications. Deliver real-time, comprehensive operational oversight through sophisticated clinical reporting, centralized resident information, in-depth analytics, and immediate access to financial insights. By streamlining record management and facilitating easier information exchange, caregivers can dedicate more time to residents while significantly reducing the risk of errors, thus enhancing the overall quality of care. This integrated approach not only fosters a more efficient workflow but also contributes to a more satisfying living experience for all residents involved.

DexCare serves as a platform-as-a-service tailored for health systems, adeptly managing digital demand alongside health system capacity across various care lines. Amidst a myriad of “point solutions,” it acts as the operational backbone that integrates all components seamlessly. It enhances accessibility by broadening the reach of health system services into innovative digital and on-demand consumer markets. By offering a fully digitized and cohesive user experience, it fosters new commercial patient acquisition while capitalizing on established investments in EMR, caregiver resources, and brand identity. Originating from Providence, one of the largest and most digitally advanced health systems in the United States, DexCare was initially crafted to facilitate same-day care. Since 2016, it has effectively driven high-value patient acquisition, navigational efficiency, and capacity optimization for the organization. The leadership team of the company is composed of seasoned professionals from healthcare and technology sectors, boasting decades of expertise in transforming health systems. Their collective knowledge positions DexCare to continuously innovate and adapt in a rapidly evolving healthcare landscape.

Cloud Pathology (CP) is transforming the landscape of diagnostics in the modern era. By leveraging cutting-edge cloud computing technology, it enhances the efficiency of pathology laboratories by an impressive 80%. This innovative system connects seamlessly with all compatible equipment, allowing for streamlined operations. Enjoy a more relaxed lifestyle as Cloud Pathology handles the more demanding tasks, enabling you to oversee processes without stress. It's designed to be the ultimate solution for managing your laboratory needs. Accessible from any device worldwide, pathologists can now review and finalize their reports without the need to rush back to the lab. This advancement not only conserves critical time but also boosts overall efficiency by 35%. Once reports are verified by the responsible physician, they can be automatically dispatched without any manual effort required. Our philosophy prioritizes automation, minimizing human involvement wherever possible. The system is programmed to alert you only when your attention is necessary, ensuring a smooth and efficient workflow. With Cloud Pathology, the future of lab management is not just promising—it's here.

TikaMSL is a business analytics, CRM, and advanced analytics tool specifically designed for MSLs. It allows Medical Science Liaisons to gain deeper insights into the industry and keep informed by connecting with multiple third party sources. It allows them to be strategic in their KOL interactions and share vital information with the rest of the organization in a fully compliant way.

Collaborative communication tools, including HIPAA-compliant texting, can significantly enhance the healthcare industry by improving speed, safety, accuracy, and overall efficiency. With the pervasive presence of smartphones, healthcare communication can now occur virtually anywhere and at any time. The adoption of mobile devices among physicians is not only widespread but also increasing at a remarkable pace. Approximately 90% of healthcare professionals in the United States utilize their personal smartphones for work-related tasks, and nearly half of clinicians are already using mobile applications to gather data at the bedside. One notable tool, DrFirst’s Backline, is specifically tailored for healthcare settings and aids providers in achieving enhanced care coordination, improved health outcomes, smoother transitions of care, and a reduction in hospital readmissions. As technology continues to evolve, the potential for these tools to further transform patient care remains vast and promising.

Navigate the complexities of the value-based care landscape by collaborating with CareSpace®. Our innovative platform integrates patient data and records from various sources, empowering you to enhance healthcare delivery. CareSpace® eliminates the need to juggle multiple technology partners by offering a comprehensive solution that encompasses care management, quality and cost oversight, analytics, data aggregation, insights, reporting, and telehealth—all in one convenient package. Unlike other programs on the market, CareSpace® truly prioritizes the patient by creating a dedicated environment centered around their needs. The seamless access and sharing capabilities foster collaboration among those involved in the patient's care, allowing for a more effective support network. Patients can connect with one another, communicate easily with their healthcare providers, share their medical histories, and receive tailored care plans—all within a single, user-friendly platform designed to enhance their overall experience. This holistic approach not only simplifies the healthcare journey but also empowers patients to take a proactive role in their health management.

Primarily, the nxtHealth Smart Technologies for Telehealth enhances patient care by extending the therapeutic experience beyond traditional clinical environments. The nxtHealth APPS offer continuous care through features that enable measurement, data collection, reporting, and exercise guidance directly on mobile devices. For instance, the nxtHealth WEARBLS work in tandem with the APPS by providing valuable data from wearable sensors. These APPS and WEARBLS are integrated smoothly via a HIPAA-compliant backend, which includes a provider portal equipped with advanced data ANALYTX capabilities. Additionally, nxtHealth enhances the quality of data, communication between patients and providers, and overall care quality through its user-friendly design and seamless integration. Furthermore, nxtHealth comprises a comprehensive array of smart technologies for telehealth aimed at supporting patient-reported outcomes (PRO), cognitive assessments, and rehabilitation efforts, ensuring a holistic approach to patient wellness.

EbixEnterprise serves as an all-encompassing solution for insurance management, effectively optimizing policy oversight throughout its entire lifecycle. The platform comprises six key elements: Customer Relationship Management (CRM), health insurance exchange, policy administration, claims administration, data analytics, and a consumer web portal. These components are interconnected, facilitating the seamless transfer of data in response to various business requirements. SmartOffice CRM empowers organizations to efficiently handle agent and broker details, commission structures, sales pipelines, and state licensing information. Furthermore, the Online Quoting Portal, HealthConnect, stands out as a premier marketplace for both buyers and sellers of health insurance and employee benefits. In addition, EbixEnterprise Administration functions as a robust policy management system, equipping users with all necessary tools to oversee policies, define insurance plans, and maintain associated rate data. This comprehensive approach not only enhances operational efficiency but also drives improved decision-making across the organization.

Reliable information is obtained from reputable sources like the Mayo Clinic and NHS, ensuring the delivery of precise content, while industry-specific NLP and NLG technologies facilitate engaging dialogues. Sensely's Insight Engine gathers user preferences to enhance the personalization of interactions. The dashboards leverage up-to-date information, offering instant and real-time insights regarding user behavior and patterns. With user-friendly design tools, customization and the creation of new interactions become effortless. Characters play a crucial role in bridging the divide between high-touch human engagement and more basic bots, providing a unique identity for your brand. Users have the capability to check symptoms and, if needed, connect with a live nurse to assist them. They also benefit from self-care options derived from a comprehensive database of medical knowledge, which empowers them to make informed health decisions. This multifaceted approach not only improves user experience but also fosters a deeper connection between technology and personal healthcare.

InformAI specializes in artificial intelligence solutions designed to enhance medical diagnostics at the point-of-care and boost the efficiency of radiologists. Our advanced AI-driven image classifiers and predictions related to patient outcomes are developed in collaboration with the Texas Medical Center, which is the largest medical center complex globally. Through partnerships with esteemed healthcare organizations, prominent physician associations, and top medical imaging firms, InformAI is revolutionizing healthcare delivery. Our team is made up of experts in the fields of healthcare, medicine, and artificial intelligence, working together to create innovations that lead to better patient results. One of our notable products, the InformAI Sinus Image Classifier, utilizes a 3D convolutional neural network (CNN) and is trained on a comprehensive library of 6 million radiology-validated 3D CT-scan images, showcasing our commitment to leveraging cutting-edge technology in the medical field. This approach not only enhances diagnostic accuracy but also contributes to more timely and effective patient care.

BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.

Transform your digital health offerings with our adaptable AI solutions. We aim to revolutionize healthcare by making it smarter and more preventive, utilizing cutting-edge technology, artificial intelligence, and seamless engagement platforms throughout the entire care spectrum. Babylon is developing innovative tools that can be integrated into your digital ecosystem, ensuring patients enjoy a fluid and cohesive experience. By joining forces, we can achieve superior clinical outcomes for your patient population through enhanced care integration and increased consumer engagement. Schedule a Babylon Video Appointment at any time, free of charge for those with certain health insurance plans. If Babylon isn't available through your insurance, you can still benefit from our complimentary chatbot and health assessment services. Transitioning the healthcare paradigm from a reactive to a preventive approach can lead to improved health outcomes and lower expenses. This is why we are merging AI-driven technology with human medical expertise to provide comprehensive healthcare solutions directly from your device, ensuring a holistic approach to well-being. Additionally, we are committed to making healthcare accessible to everyone, thus fostering a healthier community overall.

The red dot® algorithm we utilize swiftly identifies and highlights irregularities in images with remarkable precision. This advanced AI system has been crafted using a dataset of over 30,000 images, all meticulously evaluated by certified Consultant Radiologists from the UK. With continuous refinement by these highly skilled professionals, our red dot® algorithm maintains an impressive accuracy rate exceeding 90%. The ability to detect abnormalities in mere seconds ensures that patients receive diagnoses even before they leave the hospital. Furthermore, our AI technology enhances current reporting processes and seamlessly integrates with existing Radiology Information Systems (RIS) or Picture Archiving and Communication Systems (PACS), regardless of the vendor. Behold.ai has proven to be a highly cost-efficient solution, effectively alleviating reporting backlogs and capacity challenges while being up to 50% less expensive than outsourced reporting options. Recognized globally, behold.ai has earned a spot among the Top 100 Digital Health companies and is one of only five selected for AI diagnosis worldwide, showcasing its commitment to innovation in healthcare. This recognition underscores the transformative impact our technology is having on medical diagnostics and patient care.

Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.

We are a biotechnology firm in the clinical stage, dedicated to unraveling biological complexities through the integration of cutting-edge innovations spanning biology, chemistry, automation, machine learning, and engineering, all aimed at revolutionizing drug discovery. Our approach allows for enhanced precision in biological manipulation with advanced techniques like CRISPR genome editing and synthetic biology. We also achieve reliable automation for intricate laboratory processes at an unprecedented scale through the use of sophisticated robotics. By employing neural network architectures, we conduct iterative analyses and draw insights from extensive, intricate datasets generated in-house. Furthermore, we are boosting the adaptability of high-performance computing capabilities through cloud-based solutions. Our initiative harnesses new technologies to foster continuous learning cycles around our datasets, establishing us as a next-generation biopharmaceutical enterprise. This is achieved through a harmonious integration of hardware, software, and data, all dedicated to the industrialization of drug discovery. We are transforming the conventional drug discovery pipeline and boast one of the most extensive, diverse, and in-depth pipelines among technology-driven drug discovery companies. Ultimately, our mission is to enhance the efficiency and effectiveness of drug development, paving the way for breakthrough therapies.

Proteins, which are remarkably complex machines, play a crucial role not only in the biological functions of your body but also in every living organism's processes. They serve as the fundamental units of life. As of now, there are approximately 100 million identified proteins, with discoveries being made regularly. Each protein possesses a distinctive three-dimensional shape that is essential to its functionality and purpose. However, determining a protein's precise structure is often a costly and lengthy endeavor, resulting in an understanding of only a small percentage of the proteins recognized by science. Addressing this growing disparity and developing methods to predict the structures of millions of yet-to-be-discovered proteins could significantly advance our ability to combat diseases, expedite the discovery of new treatments, and potentially unveil the secrets of life's mechanisms. The implications of such advancements could transform both medicine and our understanding of biology.

adWATCH - AE is a solution designed to aid pharmaceutical companies in handling and documenting adverse events that arise during clinical trials. It provides a quick and efficient way for reporters at clinics, hospitals, or investigative sites to create and oversee Adverse Event Reports (AERs), ensuring proper reporting to regulatory bodies and government organizations. An adverse effect refers to a harmful or undesirable reaction experienced by a patient due to medications or medical devices. The process of documenting adverse events necessitates thorough tracking of all medical complaint case details, which culminates in the creation of MedWatch reports, CIOMS reports, and other management documentation. With adWATCH - AE, researchers, physician investigators, Contract Research Organizations (CROs), clinical trial experts, and various health professionals can easily generate and submit AERs in compliance with FDA requirements, adhering to both MedWatch and CIOMS formats. This streamlined process not only enhances regulatory compliance but also improves patient safety oversight during clinical trials.

The microbiome plays a significant role in various diseases and health issues. Discover how Kaleido is pioneering a unique method to transform the potential of the microbiome into effective patient solutions. Comprising over 30 trillion microbes, the human microbiome includes a diverse array of organisms such as bacteria, viruses, archaea, and fungi that inhabit both the exterior and interior of the human body. In recent years, there has been a remarkable surge in research focusing on the microbiome's influence on human health, linking it to conditions such as cardiovascular disease, cancer, diabetes, Parkinson’s disease, and allergies. This intricate microbial community has been likened to a "newly discovered organ," highlighting its significance. Just as many human organs command substantial investments for therapies that modify physiology, the microbiome represents a largely unexplored territory in the realm of healthcare. Addressing this frontier could unlock new therapeutic avenues and enhance overall health outcomes.

LigPlot+ serves as the advanced iteration of the original LIGPLOT software, designed for the automatic creation of 2D diagrams depicting ligand-protein interactions. This tool features a user-friendly Java interface that enables users to edit plots effortlessly through simple mouse click-and-drag actions. Besides the improved interface, LigPlot+ introduces several significant upgrades compared to its predecessor. When analyzing two or more ligand-protein complexes that share notable similarities, the software can automatically present their interaction diagrams either overlayed or side by side, with conserved interactions prominently highlighted for easy identification. Additionally, the LigPlot+ suite integrates an enhanced version of the original DIMPLOT program, which is focused on visualizing protein-protein or domain-domain interactions. Users have the flexibility to choose the specific interface they are interested in, allowing DIMPLOT to produce a detailed diagram that illustrates the residue-residue interactions within that interface. For further clarity in interpretation, the residues from one interface can also be displayed in their sequential order, enhancing the overall usability and functionality of the program. This comprehensive approach makes LigPlot+ a valuable tool for researchers seeking to understand complex molecular interactions more intuitively.

Uncover biological markers, generate insights into the mechanisms of disease, identify novel pharmaceuticals, or detect variations in protein concentrations through a meticulously structured series of experiments. We have simplified the process of harnessing the potential of mass spectrometry and proteomics, enabling you to concentrate on the intricacies of biology and advance toward groundbreaking discoveries. Our automated and consistent workflow facilitates faster initiation and completion of experiments, granting you the authority and adaptability to make timely decisions. By prioritizing biological insights and fostering collaborative efforts, our scalable proteomics data processing system is designed for repeated use. We have delegated intensive and repetitive tasks to the cloud, ensuring a smooth and satisfying experience. Our sophisticated proteomics workflow effectively integrates numerous complex elements, allowing for the efficient analysis and processing of larger-scale experiments, ultimately enhancing the research journey. Thus, with our innovative approach, researchers can now delve deeper into the molecular landscape and achieve more significant breakthroughs than ever before.